Le Lézard
Classified in: Health
Subjects: SVY, MAT

3CHI Demonstrates Safety and Potential Benefits of Delta 8 THC in Comprehensive Study


INDIANAPOLIS, May 2, 2024 /PRNewswire/ -- 3CHI is proud to announce the successful conclusion of a detailed tolerability and safety assessment of its Platinum Delta 8 THC oil, conducted in collaboration with Hera Biolabs. This pivotal study further confirms the safety of Delta 8 THC and showcases 3CHI's continued pioneering scientific research within the cannabinoid sector. This is the first in a series of tests that 3CHI is conducting to evaluate and further prove the safety and efficacy of its products.

3CHI Demonstrates Safety and Potential Benefits of Delta 8 THC in Comprehensive Study

In this detailed study, Sprague Dawley rats were administered various doses of 3CHI's 99% pure Platinum Delta 8 THC oil, with quantities adjusted to reflect human equivalents for an average 70 kg individual, ranging from 10 mg to 500 mg. Throughout the entire study, the rats displayed no significant adverse effects, thus confirming the product's safety at all administered doses. Importantly, the study also observed promising beneficial effects that will be explored in future clinical trials.

Justin Journay, CEO of 3CHI, stated, "This study bolsters the safety profile of our Delta 8 THC and illustrates that the criticisms leveled against delta 8 THC products and the broader hemp industry lack scientific basis and are primarily fueled by competitors' profit-driven motives?many of whom are now, hypocritically, selling hemp products."

He further noted, "Marijuana companies and their affiliated testing labs are a primary source of much of the misinformation found in the hemp industry. They simply don't have the competency to keep up with the rapid scientific advancements of the hemp industry and have fallen back on fearmongering and demonstrably false prohibitionist tactics in order to protect falling market share."

This study provides strong validation for the safety of 3CHI's Platinum Delta 8 THC oil, reinforcing its reliable safety profile even when used beyond recommended dosages.

3CHI continues to set the standard in the industry, emphasizing safety, transparency, and scientific integrity. Our proactive approach to research and unwavering commitment to quality set us apart in the dynamic cannabis market.

For additional information or to learn more about 3CHI's dedication to continuous quality and innovation, please visit our website: www.3chi.com.

Contact:
[email protected] 

SOURCE 3Chi


These press releases may also interest you

at 06:18
With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories...

at 05:50
NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd have officially entered into a dynamic strategic partnership to collaboratively focus on the future of global health and wellness. Synergistically leveraging their collective expertise...

at 05:35
Drug Farm announced today the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of DF-003, a first-in-class, oral, potent, highly selective alpha-kinase 1 (ALPK1) inhibitor for clinical evaluation in...

at 05:02
'Companion Diagnostics: Technologies and Markets' is all about using special tests alongside certain medicines to figure out which treatment will work best for each person. These tests are called companion diagnostics because they go together with...

at 05:00
WellSync, an API-driven virtual care service provider, today announced its partnership with The Vitamin Shoppe to launch Whole Health Rx, a cutting-edge telehealth service providing access to GLP-1 medications for weight management. WellSync provides...

at 04:00
May 17, 2024 Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower costs Amsterdam, the Netherlands...



News published on and distributed by: